MoonLake Immunotherapeutics - Ordinary Shares - Class A Latest Ownership Pattern - Insider, Institutional, Mutual Fund shareholdings

MoonLake Immunotherapeutics - Ordinary Shares - Class A XNAS: MLTX

6.98 -0.19 (-2.65%)

1.6M

XNAS Volume

XNAS 01 Oct, 2025 9:41 AM (EDT)

Trial Setback

MoonLake falls on Monday as late-stage skin disease drug trial shows weaker-than-expected results See details